Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.16 USD
−6.47 M USD
3.18 M USD
About Starpharma Holdings Limited
Sector
Industry
CEO
Cheryl Maley
Website
Headquarters
Abbotsford
Founded
1997
ISIN
US8555631022
FIGI
BBG000G50RY3
Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its pipeline and products include SN38, cabazitaxel, docetaxel, radiopharmaceuticals, antibody-drug conjugates, and anti-infective products. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Related stocks
$SPL ASX - Starpharma Holdings might be a small playStarpharma Holdings Limited (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications. SPL's underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and
Speculative Stockpick #2SPL is a highly speculative stock (refer VectorVest Strategic Investment Matrix) with RV <1.0 and RS = 1.0.
We only consider this stock for very short term because of its explosive potential… A strong RT value.
The RT value is trending up since the confirmation of bullish abandoned baby which is
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.